Previously known as Physicians and Scientists for Responsible Genetics PSRGNZ - Charitable Trust
As required under the new 2005 Charities Act, PSGR has reregistered as a charitable trust.

Mike Godfrey qualified LRCP.MRCS (England) and MBBS (London) in 1963. He joined a General Practice in Mt Maunganui, New Zealand in 1971, after seven years in various hospital posts in England. He left general practice in 1986 to establish an environmental health and chelation clinic in Tauranga.

Dr Godfrey is a founding member and past-President of the NZ Academy of Oral Medicine and Toxicology, and a Clinical Associate of the Graduate School of Integrative Medicine, Swinburn University, Melbourne.

Post-graduate qualifications and appointments:

1989 Diploma American Board of Chelation Therapy. Recertified 1994,1999;
1991 Fellow of American College of Advancement in Medicine (FACAM);
1996 Fellow of Australasian College of Nutrition and Environmental Medicine
2000 Clinical Associate (visiting lecturer) Swinburne University, Melbourne;
2003 Board member of International Board of Clinical Metal Toxicology.

Conference presentations:

Dr Godfrey has presented 14 clinical papers at post-graduate medical conferences in America, Australia, Germany, India and New Zealand between 1989 and 2007. He was a lecturer for chelation and heavy metal toxicity at Fellowship training courses for the ACNEM, Melbourne, 1998-2004, and Auckland Medical School GP CME training in 1999.


  1. Chronic illness in association with dental amalgam: Report of two cases. J. Advanced Medicine 1990;3(4):247-255.
  2. Dental Amalgam - a potentially toxic source of mercury? NZ Science Review, 1992;49(2):52-56
  3. Confirmation of mercury retention and toxicity using Dimercapto-1-propane-sulphonic acid sodium salt (DMPS). Godfrey M E, Campbell N, J. Advanced Medicine, 1994;7(1):19-30
  4. Improved results in cancer therapies: Biological adjuncts and non-surgical alternatives to standard cancer therapies. J. Advanced Medicine, 1996;9(1):59-68.
  5. Candida, Dysbiosis and Amalgam. J. Advanced Medicine, 1996;9(2):115-120.
  6. A dental focus as a cause of trigeminal neuralgia: Case report. J. Advanced Medicine, 1997;10(4):267-272
  7. Dental Amalgam and Human Health - Current Situation. Cutress T W, Godfrey M E, Miller J H and Whyman R E, 1997. Health Department, Government Publication, Wellington, NZ.
  8. Dental Amalgam and Senile Dementia. NZ Science Review. 1998;55(4):141-144.
  9. The pathophysiology of long-term exposure to dental amalgam: A potential hazard for senile dementia. Godfrey M E and Huggins H A. J. Clinical Applied Alternative Medicine, 2000;1(2):107-12
  10. Apolipoprotein E Genotyping as a potential Biomarker for Mercury Neurotoxicity. Godfrey M E, Wojcik D P, Krone C A. J. Alzheimer’s Diseases, (2003):5(3):189-193
  11. Is Bio-Resonance the 21st Century’s New Medicine? Godfrey M E. J. Australian College of Nutrition and Environmental Medicine, 2004;23(1):9-11.
  12. Haemorrhagic meningococcal meningitis: is it scurvy? Godfrey M E. NZ Medical Journal, 20 August 2004, vol.117, No.1200.
  13. Mercury toxicity presenting as chronic fatigue, memory impairment and depression. Wojcik D P, Godfrey M E, Christie D and Haley B E. Neuroendocrin. Letters (2006) 27(4):415-423.

Dr Godfrey is a Trustee of Physicians and Scientists for Responsible Genetics.

May 2008

Clinical Thermography Limited, Tauranga, New Zealand